These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 6404149)

  • 41. Clinical response and effects on left ventricular function of isosorbide dinitrate added to propranolol or diltiazem monotherapy in patients with chronic stable angina.
    Humen DP; Kostuk WJ
    Can J Cardiol; 1991 Mar; 7(2):74-80. PubMed ID: 2049686
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Variability of response to beta receptor blockade for angina pectoris in clinical trials: a study of pindolol.
    Harston WE; Friesinger GC
    Am J Cardiol; 1982 Oct; 50(4):722-7. PubMed ID: 6127028
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Evaluation of oxprenolol slow release and osmotic release by exercise testing and ambulatory electrocardiographic monitoring in patients with chronic stable angina pectoris.
    Bowles MJ; Khurmi NS; O'Hara MJ; Raftery EB
    Eur J Clin Pharmacol; 1987; 32(2):127-33. PubMed ID: 3556193
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparative effects of verapamil and propranolol in patients with angina pectoris.
    de Oliveira JM
    Arq Bras Cardiol; 1978 Feb; 31 Suppl 1():45-50. PubMed ID: 98137
    [No Abstract]   [Full Text] [Related]  

  • 45. Prolonged action of pindolol.
    Nigam PD; Malhotra AS
    Br Med J; 1973 Mar; 1(5855):742-3. PubMed ID: 4571755
    [No Abstract]   [Full Text] [Related]  

  • 46. [Treatment of patients with stable angina by combination of trinitrolong and propranolol].
    Kukushkin SK; Metelitsa VI; Kokurina EV; Bochkarëva EV
    Klin Med (Mosk); 1993; 71(5):30-3. PubMed ID: 8301980
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect on exercise tolerance and pharmacokinetics of conventional and sustained release preparations of propranolol in patients with angina pectoris--a double-blind cross-over study.
    Kambara H; Kinoshita M; Hirota Y; Kadota K; Sawamura M; Saito T; Kawai C
    Jpn Circ J; 1984 Oct; 48(10):1066-73. PubMed ID: 6387210
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparison of antianginal efficacy of one conventional and three long acting beta-adrenoreceptor blocking agents in stable angina pectoris.
    Jones GR; Mir MA
    Br Heart J; 1981 Nov; 46(5):503-7. PubMed ID: 6119104
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Exercise capacity with transdermal nitroglycerin in patients with stable angina pectoris.
    Naafs MA; de Boer AC; Koster RW; Klazen CW; Dunning AJ
    Eur Heart J; 1984 Sep; 5(9):705-9. PubMed ID: 6437815
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Efficacy of sustained-release verapamil in chronic stable angina pectoris.
    Weiner DA; Klein MD; Cutler SS
    Am J Cardiol; 1987 Feb; 59(4):215-8. PubMed ID: 3544792
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Oral sustained-release nitroglycerin in chronic stable angina: a multicenter, double-blind, randomized crossover trial.
    Berkenboom GM; Sobolski JC; Degre SG
    Am J Cardiol; 1984 Jan; 53(1):15-7. PubMed ID: 6419574
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparison of nitroglycerin-TTS and long-acting nitroglycerin tablets in the treatment of angina pectoris: a double-blind controlled study.
    Karlson BW; Henning R
    Clin Cardiol; 1987 Oct; 10(10):573-7. PubMed ID: 3117467
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effects of a transdermal patch system containing nitroglycerin on exercise tolerance in patients with angina pectoris. Double-blind, placebo controlled, comparison with slow-release nifedipine and verapamil.
    Gibelli G; Negrini M; Mazzocchi F; Prina L; Pollavini P; De Ponti C
    G Ital Cardiol; 1986 Nov; 16(11):904-8. PubMed ID: 3104124
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A new oral slow release form of isosorbide dinitrate. Effect on the hemodynamics and exercise capacity of patients with angina.
    Di Bianco R; Ronan JA; Donohue DJ; Lindgren KM
    Chest; 1983 Dec; 84(6):707-13. PubMed ID: 6641305
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparative antianginal effects of bepridil and propranolol in angina pectoris.
    Parker JO; Farrell B
    Am J Cardiol; 1986 Sep; 58(6):449-52. PubMed ID: 3529909
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Double-blind titrated-dose comparison of metoprolol and propranolol in the treatment of angina pectoris.
    Frick MH; Luurila O
    Ann Clin Res; 1976 Dec; 8(6):385-92. PubMed ID: 795362
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Once daily administration of sustained release propranolol capsules in the treatment of angina pectoris.
    Halkin H; Vered I; Saginer A; Rabinowitz B
    Eur J Clin Pharmacol; 1979; 16(6):387-91. PubMed ID: 393520
    [No Abstract]   [Full Text] [Related]  

  • 58. Blood pressure reactivity in the evaluation of resting blood pressure and mood responses to pindolol and propranolol in hypertensive patients.
    Potempa KM; Fogg LF; Fish AF; Kravitz HM
    Heart Lung; 1993; 22(5):383-91. PubMed ID: 8226001
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Double blind trial of propranolol and pindolol in angina pectoris.
    Ilyas M; Jafary MH; Peracha MA; Janjua M; Khan N
    J Pak Med Assoc; 1975 Jul; 25(7):165-6. PubMed ID: 815634
    [No Abstract]   [Full Text] [Related]  

  • 60. Verapamil and beta-adrenoceptor blockade in the treatment of stable angina pectoris.
    Hansen JF; Grytter C; Thomsen S; Sigurd B
    Clin Exp Pharmacol Physiol Suppl; 1982; 6():31-41. PubMed ID: 6126287
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.